Cargando…
A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer
Objectives: Src family kinases (SFKs) are expressed in non-small cell lung cancer (NSCLC) and may be involved in tumor growth and metastases. Inhibition of SFK may also enhance radiation. The purpose of this study was to evaluate if a maximum dose of 100 mg of dasatinib could be safely administered...
Autores principales: | Khurshid, Humera, Dipetrillo, Thomas, Ng, Thomas, Mantripragada, Kalyan, Birnbaum, Ariel, Berz, David, Radie-Keane, Kathy, Perez, Kimberly, Constantinou, Maria, Luppe, Denise, Schumacher, Andrew, Leonard, Kara, Safran, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364482/ https://www.ncbi.nlm.nih.gov/pubmed/22666662 http://dx.doi.org/10.3389/fonc.2012.00056 |
Ejemplares similares
-
Targeting Genomic Alterations in Squamous Cell Lung Cancer
por: Mantripragada, Kalyan, et al.
Publicado: (2013) -
Response to Anti-PD-1 Therapy in Metastatic Merkel Cell Carcinoma Metastatic to the Heart and Pancreas
por: Mantripragada, Kalyan, et al.
Publicado: (2015) -
Recurrence of Paraneoplastic Membranous Glomerulonephritis Following Chemoradiation in a Man With Non-Small-Cell Lung Carcinoma
por: Crawford, Andrew R., et al.
Publicado: (2013) -
Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab
por: Diamond, Brett H., et al.
Publicado: (2022) -
Concurrent Chemoradiation for Vaginal Cancer
por: Miyamoto, David T., et al.
Publicado: (2013)